Affinage

LRMDA

Leucine-rich melanocyte differentiation-associated protein · UniProt Q9H2I8

Length
198 aa
Mass
22.6 kDa
Annotated
2026-04-28
33 papers in source corpus 6 papers cited in narrative 6 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

LRMDA is a leucine-rich repeat protein that functions as a RAB32/RAB38 effector and scaffold for endosomal recycling complexes, with essential roles in melanosome biogenesis and innate immune cell trafficking. LRMDA localizes to the melanosome limiting membrane via interaction with active RAB32 and RAB38, and simultaneously binds the Commander recycling complex; this RAB32-LRMDA-Commander assembly is required for PMEL processing and fibrillation (stage I-to-II melanosome transition), organelle acidification, and melanin production, and its disruption by patient mutations causes oculocutaneous albinism type 7 (OCA7) (PMID:36334630, PMID:41038817, PMID:23395477). In myeloid innate immune cells, LRMDA acts downstream of TRPV2-mediated Ca²⁺ influx to regulate plasma membrane tension and mobility, thereby controlling viral penetration and infection (PMID:36261399). LRMDA also cooperatively interacts with Rab32 and the Retriever complex in mucosal dendritic cells and macrophages to regulate endolysosomal trafficking required for intestinal immune homeostasis and bacterial clearance (PMID:40791432).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 2008 Medium

    Before any mammalian function was known, epistasis analysis in Ciona intestinalis established that the LRMDA ortholog acts upstream of or parallel to β-catenin in canonical Wnt signaling during early embryogenesis, providing the first evidence that this leucine-rich repeat protein participates in developmental signaling.

    Evidence Morpholino knockdown in Ciona with constitutively active β-catenin rescue and dosage-sensitive interaction assays

    PMID:18336583

    Open questions at the time
    • Relevance of Wnt-pathway function to mammalian LRMDA has not been tested
    • Direct molecular target within the Wnt pathway remains unidentified
    • Whether this developmental role extends to melanocyte or immune lineages is unknown
  2. 2013 High

    LRMDA was identified as a melanocyte-differentiation gene: it is expressed in melanoblasts and melanocytes in human fetal tissue, and loss of function in zebrafish caused reduced pigmentation and melanocyte number, rescued by wild-type but not mutant protein — establishing its requirement for pigmentation and linking it to OCA7.

    Evidence Immunohistochemistry on human fetal tissue; morpholino knockdown in zebrafish with wild-type and mutant rescue

    PMID:23395477

    Open questions at the time
    • Molecular mechanism by which LRMDA promotes melanocyte differentiation or pigmentation was unknown
    • Subcellular localization and binding partners had not been identified
    • Whether the pigmentation defect reflects melanosome biogenesis failure or melanocyte specification defect was unclear
  3. 2022 High

    The mechanism of LRMDA in melanosome biogenesis was elucidated: LRMDA localizes to the melanosome limiting membrane via RAB32/RAB38 effector binding, and its loss impairs PMEL processing, organelle acidification, and the stage I-to-II melanosome transition — resolving how LRMDA controls pigmentation at the organelle level.

    Evidence OCA7-KO MNT1 melanocyte cell lines; live imaging and immunofluorescence; pulldown with Rab32/Rab38; PMEL processing and luminal pH assays

    PMID:36334630

    Open questions at the time
    • How LRMDA regulates organelle pH mechanistically was not resolved
    • Downstream trafficking machinery recruited by LRMDA was not identified
    • Structural basis of the RAB32/38-LRMDA interaction was unknown
  4. 2022 High

    A non-melanocyte function was discovered: in myeloid innate immune cells, LRMDA acts downstream of TRPV2-mediated Ca²⁺ influx to regulate membrane tension and mobility, controlling viral penetration — revealing that LRMDA has cell-type-specific roles beyond pigmentation.

    Evidence TRPV2 conditional KO mice; shRNA knockdown and LRMDA reconstitution in BMDCs/BMDMs; membrane tension, mobility, and viral infection assays

    PMID:36261399

    Open questions at the time
    • Mechanism linking LRMDA to membrane tension changes is unknown
    • Whether the membrane tension function involves RAB32 or vesicular trafficking was not tested
    • Relevance to in vivo antiviral immunity was not demonstrated
  5. 2025 High

    The molecular architecture of the RAB32-LRMDA-Commander complex was resolved: LRMDA simultaneously and independently binds active RAB32 and the Commander endosomal recycling assembly (via a surface shared with SNX17), and OCA7-causing patient mutations specifically uncouple these two interactions — establishing the disease mechanism.

    Evidence Unbiased proteomics, recombinant protein reconstitution, co-immunoprecipitation, computational modelling, OCA7 patient mutation analysis, functional assays in human melanocytes

    PMID:41038817

    Open questions at the time
    • High-resolution structure of the ternary complex has not been determined
    • Cargo specificity of LRMDA-Commander versus SNX17-Commander is unclear
    • Whether Commander engagement explains the organelle pH defect remains untested
  6. 2025 High

    An analogous Rab32-LRMDA-Retriever complex was shown to operate in mucosal innate immune cells (DCs and macrophages) to regulate endolysosomal trafficking, intestinal immune homeostasis, and bacterial clearance — extending the scaffold model to a second cell type and recycling complex.

    Evidence ENU forward genetic screen with CRISPR/Cas9 validation; hematopoietic chimeras and conditional knockouts; proteomic and biochemical interaction studies; DSS colitis and Listeria infection models (preprint)

    PMID:40791432

    Open questions at the time
    • Awaits peer review
    • Whether Commander and Retriever interactions are truly mutually exclusive or can coexist in immune cells is unresolved
    • Specific endolysosomal cargoes regulated by LRMDA-Retriever are not identified

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key open questions include the structural basis of how LRMDA simultaneously engages RAB32 and distinct endosomal recycling complexes (Commander vs. Retriever), the identity of cargoes sorted by LRMDA-containing complexes in immune cells, and whether the membrane tension function in myeloid cells involves the same RAB32-dependent trafficking mechanism.
  • No high-resolution structure of any LRMDA complex exists
  • Cargo specificity in immune cells has not been defined
  • Relationship between Ca²⁺-dependent membrane tension function and RAB32-recycling complex function is unexplored

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2
Localization
GO:0005768 endosome 2 GO:0043226 organelle 2
Pathway
R-HSA-5653656 Vesicle-mediated transport 3 R-HSA-168256 Immune System 2 R-HSA-1852241 Organelle biogenesis and maintenance 2
Complex memberships
RAB32-LRMDA-CommanderRab32-LRMDA-Retriever

Evidence

Reading pass · 6 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2013 C10orf11 (LRMDA) encodes a leucine-rich repeat protein expressed in melanoblasts and melanocytes (but not retinal pigment epithelium) in human fetal tissue; knockdown of the zebrafish homolog with morpholinos caused substantially decreased pigmentation and reduced number of pigmented melanocytes, a phenotype rescued by wild-type but not mutant C10orf11, establishing it as a melanocyte-differentiation gene required for pigmentation. Immunohistochemistry (human fetal tissue), morpholino knockdown in zebrafish with wild-type and mutant rescue American journal of human genetics High 23395477
2008 The Ciona intestinalis ortholog of C10orf11 (Ci-C10orf11), encoding a leucine-rich repeat protein, acts upstream of or parallel to beta-catenin in the canonical Wnt/beta-catenin signaling pathway during early embryogenesis; morpholino knockdown suppressed beta-catenin target gene expression and endoderm formation, rescued only by constitutively active (not wild-type) beta-catenin. Morpholino loss-of-function screen in Ciona; epistasis analysis with constitutively active beta-catenin rescue; dosage-sensitive interaction assays Development, growth & differentiation Medium 18336583
2022 OCA7 (C10orf11/LRMDA) localizes to the limiting membrane of melanosomes via interaction with Rab32 and Rab38 through a canonical effector-binding surface; loss of OCA7 in MNT1 cells impairs melanosome maturation, disrupts PMEL processing and fibrillation (stage I-to-II transition), and reduces melanosome lumen pH, collectively decreasing melanin levels. Fluorescence localization (live imaging and immunofluorescence), OCA7-KO cell line generation, pulldown with Rab32/Rab38, PMEL processing assays, pH measurement The Journal of biological chemistry High 36334630
2022 TRPV2-mediated Ca2+ influx in myeloid cells upregulates Lrmda expression; Lrmda knockdown reduces cell membrane tension and mobility and inhibits viral (HSV-1, VSV) penetration and infection, while LRMDA complementation in TRPV2-KO dendritic cells partially restores membrane tension/mobility and viral penetration, placing LRMDA downstream of Ca2+ in the TRPV2-Ca2+-LRMDA axis controlling viral entry. TRPV2 conditional knockout mice, shRNA knockdown of Lrmda, LRMDA reconstitution, membrane tension/mobility assays, viral infection assays in BMDCs/BMDMs Advanced science (Weinheim, Baden-Wurttemberg, Germany) High 36261399
2025 LRMDA is a component of a RAB32-LRMDA-Commander membrane trafficking complex; LRMDA simultaneously binds active RAB32 and the endosomal Commander assembly through a mechanism shared with SNX17 (but mutually exclusive with SNX17-Commander), and this complex is essential for melanosome biogenesis and pigmentation. OCA7-causing LRMDA mutations uncouple RAB32 binding from Commander binding, establishing the molecular mechanism of disease. Unbiased proteomics, recombinant protein reconstitution, co-immunoprecipitation, computational modelling, functional analysis in human melanocytes, OCA7 patient mutation analysis Nature communications High 41038817
2025 LRMDA functions primarily in CD11c+ innate immune cells (mucosal dendritic cells and macrophages) to regulate endolysosomal trafficking; LRMDA directly and cooperatively interacts with Rab32 and the endosomal recycling complex Retriever. Loss of LRMDA increases susceptibility to DSS-induced colitis and impairs clearance of Listeria monocytogenes, establishing the Rab32-LRMDA-Retriever complex as a critical regulator of intestinal immune homeostasis. ENU forward genetic screen, CRISPR/Cas9 validation, hematopoietic chimeras, conditional knockouts, proteomic/biochemical interaction analyses, DSS colitis model, Listeria infection assay bioRxivpreprint High 40791432

Source papers

Stage 0 corpus · 33 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2013 Increasing the complexity: new genes and new types of albinism. Pigment cell & melanoma research 149 24066960
2014 Mutational analysis of oculocutaneous albinism: a compact review. BioMed research international 92 25093188
2013 Mutations in c10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinism. American journal of human genetics 83 23395477
2016 DNA methylation profiling in human lung tissue identifies genes associated with COPD. Epigenetics 73 27564456
2011 A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese. Human molecular genetics 52 22180457
2019 A pathogenic haplotype, common in Europeans, causes autosomal recessive albinism and uncovers missing heritability in OCA1. Scientific reports 37 30679655
2022 The Transient Receptor Potential Vanilloid 2 (TRPV2) Channel Facilitates Virus Infection Through the Ca2+ -LRMDA Axis in Myeloid Cells. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 24 36261399
2015 Pharmacogenomics toward personalized tamoxifen therapy for breast cancer. Pharmacogenomics 21 25712191
2020 Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants. PloS one 20 32966289
2009 Chromosome aberrations involving 10q22: report of three overlapping interstitial deletions and a balanced translocation disrupting C10orf11. European journal of human genetics : EJHG 19 19844253
2008 Novel genes involved in canonical Wnt/beta-catenin signaling pathway in early Ciona intestinalis embryos. Development, growth & differentiation 15 18336583
2022 Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review. Genes 14 35741834
2022 OCA7 is a melanosome membrane protein that defines pigmentation by regulating early stages of melanosome biogenesis. The Journal of biological chemistry 14 36334630
2017 Genetic diseases associated with an increased risk of skin cancer development in childhood. Current opinion in pediatrics 11 28525403
2016 Homozygosity mapping in albinism patients using a novel panel of 13 STR markers inside the nonsyndromic OCA genes: introducing 5 novel mutations. Journal of human genetics 9 26818737
2017 Ophthalmo-genetic analysis of Pakistani patients with nonsyndromic oculocutaneous albinism through whole exome sequencing. JPMA. The Journal of the Pakistan Medical Association 8 28507374
2013 SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies. Gene 8 24096233
2020 Mapping the TYR gene reveals novel and previously reported variants in Eastern Indian patients highlighting preponderance of the same changes in multiple unrelated ethnicities. Annals of human genetics 6 32115698
2025 Proteomic biomarkers of emphysema-predominant and non-emphysema-predominant chronic obstructive pulmonary disease. EBioMedicine 5 40505416
2024 Clinical and mutational characteristics of oculocutaneous albinism type 7. Scientific reports 5 38555393
2022 Variants influencing age at diagnosis of HNF1A-MODY. Molecular medicine (Cambridge, Mass.) 5 36104811
2020 Identification and Computational Analysis of Novel TYR and SLC45A2 Gene Mutations in Pakistani Families With Identical Non-syndromic Oculocutaneous Albinism. Frontiers in genetics 5 32849781
2022 NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism. BMC genomics 3 35488210
2016 De Novo 1.77-Mb Microdeletion of 10q22.2q22.3 in a Girl With Developmental Delay, Speech Delay, Congenital Cleft Palate, and Bilateral Hearing Impairment. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 3 27031267
2025 Genome-wide association study identifies novel genetic variants associated with widespread pain in the UK Biobank (N = 172,230). Molecular pain 2 40509746
2024 DNA Methylation Patterns Associated with Tinnitus in Young Adults-A Pilot Study. Journal of the Association for Research in Otolaryngology : JARO 2 39147981
2019 Clinical and molecular findings of FRMD7 related congenital nystagmus as adifferential diagnosis of ocular albinism. Ophthalmic genetics 2 30942644
2019 Clinical and molecular cytogenetic characterization of a novel 10q interstitial deletion: a case report and review of the literature. Molecular cytogenetics 2 31131026
2025 The Rab32-LRMDA-Retriever Complex is a Key Regulator of Intestinal Immune Homeostasis. bioRxiv : the preprint server for biology 1 40791432
2025 Genomic landscape of endometrial polyps. Genome medicine 1 41137179
2025 Identification of a RAB32-LRMDA-Commander membrane trafficking complex reveals the molecular mechanism of human oculocutaneous albinism type 7. bioRxiv : the preprint server for biology 0 39975051
2025 Identification of a RAB32-LRMDA-Commander membrane trafficking complex reveals the molecular mechanism of human oculocutaneous albinism type 7. Nature communications 0 41038817
2023 Whole genome sequencing analysis of four patients: Are de novo copy number variations in non-coding region responsible for microtia with lung hypoplasia? International journal of pediatric otorhinolaryngology 0 37329699